FDA.reportPublic FDA data

betaxolol HCl 0.25 % Ophthalmic Suspension

RxCUI
308719
RxNorm name
betaxolol HCl 0.25 % Ophthalmic Suspension
Display name
betaxolol HCl 0.25 % Ophthalmic Suspension
Full name
betaxolol HCl 0.25 % Ophthalmic Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Betoptic SBETAXOLOL HYDROCHLORIDENovartis Pharmaceuticals Corporation905ba189-456c-4aa4-8231-39a971374ad82025-01-22Warnings, Adverse reactionsExact identifier
rxcui: 308719

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
905ba189-456c-4aa4-8231-39a971374ad8betaxolol HCl 0.25 % Ophthalmic SuspensionPSN4These highlights do not include all the information needed to use BETOPTIC S safely and effectively. See full prescribing information for BETOPTIC S. BETOPTIC S ® (betaxolol hydrochloride ophthalmic suspension), 0.25% as base, for topical ophthalmic use Initial U.S. Approval: 198520250122
905ba189-456c-4aa4-8231-39a971374ad8betaxolol 0.25 % Ophthalmic SuspensionSY4These highlights do not include all the information needed to use BETOPTIC S safely and effectively. See full prescribing information for BETOPTIC S. BETOPTIC S ® (betaxolol hydrochloride ophthalmic suspension), 0.25% as base, for topical ophthalmic use Initial U.S. Approval: 198520250122
905ba189-456c-4aa4-8231-39a971374ad8betaxolol 2.5 MG/ML Ophthalmic SuspensionSCD4These highlights do not include all the information needed to use BETOPTIC S safely and effectively. See full prescribing information for BETOPTIC S. BETOPTIC S ® (betaxolol hydrochloride ophthalmic suspension), 0.25% as base, for topical ophthalmic use Initial U.S. Approval: 198520250122
905ba189-456c-4aa4-8231-39a971374ad8betaxolol 2.5 MG/ML (betaxolol hydrochloride 2.8 MG/ML) Ophthalmic SuspensionSY4These highlights do not include all the information needed to use BETOPTIC S safely and effectively. See full prescribing information for BETOPTIC S. BETOPTIC S ® (betaxolol hydrochloride ophthalmic suspension), 0.25% as base, for topical ophthalmic use Initial U.S. Approval: 198520250122
4dd69142-d320-40d9-ad27-680b2fe7fd42betaxolol 2.5 MG/ML (betaxolol hydrochloride 2.8 MG/ML) Ophthalmic SuspensionSY1Betoptic®Pilo Ophthalmic Suspension (betaxolol 0.25% / pilocarpine hydrochloride 1.75% ophthalmic suspension)20060619
4dd69142-d320-40d9-ad27-680b2fe7fd42betaxolol 2.5 MG/ML Ophthalmic SuspensionSCD1Betoptic®Pilo Ophthalmic Suspension (betaxolol 0.25% / pilocarpine hydrochloride 1.75% ophthalmic suspension)20060619
4dd69142-d320-40d9-ad27-680b2fe7fd42betaxolol HCl 0.25 % Ophthalmic SuspensionPSN1Betoptic®Pilo Ophthalmic Suspension (betaxolol 0.25% / pilocarpine hydrochloride 1.75% ophthalmic suspension)20060619
4dd69142-d320-40d9-ad27-680b2fe7fd42betaxolol 0.25 % Ophthalmic SuspensionSY1Betoptic®Pilo Ophthalmic Suspension (betaxolol 0.25% / pilocarpine hydrochloride 1.75% ophthalmic suspension)20060619